Evidence map›Paper›PMID 19152208›Full record

ReviewJournal of neurogenetics2009

Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence.

George R Uhl, Tomas Drgon, Catherine Johnson, Qing-Rong Liu

Abstract readReview
In one paragraph

Review in Journal of neurogenetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. A genome-wide investigation of food addiction.Obesity (Silver Spring, Md.) · 2016
    Article
  3. Review
  4. Article
  5. Future pharmacological treatments for substance use disorders.British journal of clinical pharmacology · 2014
    Review
  6. Article
  7. Article
  8. Linkage analyses of stimulant dependence, craving, and heavy use in American Indians.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2011
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

George R UhlMolecular Neurobiology Branch, NIH-IRP (NIDA), Baltimore, Maryland 21224, USA. guhl@intra.nida.nih.gov
Tomas Drgon
Catherine Johnson
Qing-Rong Liu

Funding

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: HumansZIADA000401 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2015
$3.4M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Abundant evidence from family, adoption, and twin studies point to large genetic contributions to individual differences in vulnerability to develop dependence on one or more addictive substances. Twin data suggest that most of this genetic vulnerability is shared by individuals who are dependent on a variety of addictive substances. Molecular genetic studies, especially genomewide and candidate gene association studies, have elucidated common haplotypes in dozens of genes that appear to make polygenic contributions to vulnerability to developing dependence. Most genes that harbor currently identified addiction-associated haplotypes are expressed in the brain. Haplotypes in many of the same genes are identified in genomewide association studies that compare allele frequencies in substance dependent vs. control individuals from European, African, and Asian racial/ethnic backgrounds. Many of these addiction-associated haplotypes display pleiotropic influences on a variety of related brain-based phenotypes that display 1) substantial heritability and 2) clinical cooccurence with substance dependence.

Indexed as

Genetic Predisposition to DiseaseCarrier ProteinsCell AdhesionCognition DisordersCytokinesFrontal LobeGene FrequencyGenetic Association StudiesHaplotypesHumansModels, GeneticMultifactorial InheritancePersonality DisordersPhenotypeSubstance-Related DisordersCarrier ProteinsCytokinespleiotrophin

Identifiers

PMID19152208
PMCPMC4898946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.